Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
biotech
national top stories
pfizer
san francisco blog main
amgen
boston blog main
boston top stories
national
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco top stories
startups
abbvie
adverum biotechnologies
alzheimer's disease
archive
artificial intelligence
boulder/denver blog main
boulder/denver top stories
coronavirus
cystic fibrosis
deals
detroit blog main
detroit top stories
diagnostics
gilead sciences
indiana blog main
indiana top stories
medicine
merck
novartis
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
What
ceo
9
×
drug
9
×
announced
medicine
pfizer
treatment
acquisitions
big
biggest
bio
company
company’s
covid
early
gilead
maker
new
question
roundup
sciences
today
treat
use
week
year
according
aces
addressed
albert
alex
amyotrophic
andme
anne
answers
arm
artificial
athena
benevolentbio
benevolentbio’s
better
Language
unset
unknown
Current search:
drug
×
ceo
×
@slashgear.com
3 years ago
Pfizer may release an at-home COVID-19 treatment before the holidays
@xconomy.com
4 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@slashgear.com
4 years ago
Gilead CEO answers big COVID-19 question: How much will remdesivir cost
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
5 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@extremetech.com
6 years ago
23andMe, GlaxoSmithKline Will Use Your DNA to Develop New Drugs
@techcrunch.com
7 years ago
BenevolentBio’s artificial intelligence could discover a better treatment for ALS